The role of cell transplantation in modifying the course of limb girdle muscular dystrophy: a longitudinal 5-year study

References

• Mitsuhashi S, Kang PB. Update on the genetics of limb girdle muscular dystrophy. Semin Pediatr Neurol. 2012;19:211–218.23245554
   PubMed Web of Science ®Google Scholar
• Zatz M, Vainzof M, Passos-Bueno MR. Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol. 2000;13(5):511–517.11073356
   PubMed Web of Science ®Google Scholar
• Pegoraro E, Hoffman EP. Limb-Girdle Muscular Dystrophy Overview In: Pagon RA, Adam MP, Ardinger HH, et al, editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle: 2000 [ updated August 30, 2012].
   Google Scholar
• Meregalli M, Farini A, Parolini D, Maciotta S, Torrente Y. Stem cell therapies to treat muscular dystrophy: progress to date. BioDrugs. 2010;24(4):237–247.20623990
   PubMed Web of Science ®Google Scholar
• Bittner RE, Schöfer C, Weipoltshammer K, et al Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl). 1999;199:391–396.10221450
   PubMedGoogle Scholar
• Sharma A, Gokulchandran N, Chopra G, et al Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplant. 2012;21 Suppl 1:S79–S90.22507683
   PubMed Web of Science ®Google Scholar
• Sharma A, Paranjape A, Sane H, Bhagawanani K, Gokulchandran N, Badhe P. Cellular transplantation alters the disease progression in Becker’s muscular dystrophy. Case Rep Transplant. 2013;2013:909328.23841012
   PubMedGoogle Scholar
• Luth ES, Jun SJ, Wessen MK, Liadaki K, Gussoni E, Kunkel LM. Bone marrow side population cells are enriched for progenitors capable of myogenic differentiation. J Cell Sci. 2008;121:1426–1434.18397996
   PubMed Web of Science ®Google Scholar
• Carlson RV, Boyd KM, Webb DJ. The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol. 2004;57: 695–713.15151515
   PubMed Web of Science ®Google Scholar
• Rider LG, Koziol D, Giannini EH, et al Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2010;62(4): 465–472.20391500
   PubMed Web of Science ®Google Scholar
• Ottenbacher KJ1, Hsu Y, Granger CV, Fiedler RC. The reliability of the functional independence measure: A quantitative review. Arch Phys Med Rehabil. 1996;77(12):1226–1232.8976303
   PubMed Web of Science ®Google Scholar
• Stineman MG, Shea JA, Jette A, et al The Functional Independence Measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories. Arch Phys Med Rehabil. 1996;77:1101–1108.8931518
   PubMed Web of Science ®Google Scholar
• Urdzíková L1, Jendelová P, Glogarová K, Burian M, Hájek M, Syková E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma. 2006;23(9):1379–1391.16958589
   PubMed Web of Science ®Google Scholar
• Salani S, Donadoni C, Rizzo F, Bresolin N, Comi GP, Corti S. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. J Cell Mol Med. 2012;16:1353–1364.22129481
   PubMed Web of Science ®Google Scholar
• McArdle A, Edwards RH, Jackson MJ. How does dystrophin deficiency lead to muscle degeneration?–evidence from the mdx mouse. Neuromuscul Disorder. 1995;5:445–456.
   Web of Science ®Google Scholar
• Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol. 1986:69:91–95.3962599
   PubMed Web of Science ®Google Scholar
• Watkins SC, Cullen MJ. A quantitative study of myonuclear and satellite cell nuclear size in Duchenne muscular dystrophy, polymyositis and normal human skeletal muscle. Anat Rec. 1988;222:6–11.3189887
   PubMedGoogle Scholar
• Vainzof M, Passos-Bueno MR, Pavanello RC, Marie SK, Oliveira AS, Zatz M. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population. J Neurol Sci. 1999;164:44–49.10385046
   PubMed Web of Science ®Google Scholar
• Alok S, Prerna B, Nandini G, et al Stem cell therapy and other advances in muscular dystrophy In: Stem Cell Therapy in Muscular Dystrophy. NeuroGen Publication 2014;(1):1–13.
   Google Scholar
• Brussee V, Tardif F, Roy B, Goulet M, Sebille A, Tremblay JP. Successful myoblast transplantation in fibrotic muscles: no increased impairment by the connective tissue. Transplantation. 1999;67:1618–1622.10401771
   PubMed Web of Science ®Google Scholar
• Vilquin JT. Myoblast transplantation: clinical trials and perspectives. Mini-review. Acta Myol. 2005;24:119–127.16550929
   PubMedGoogle Scholar
• Sharma A, Kulkarni P, Chopra G, Gokulchandran N, Lohia M, Badhe P. autologous bone marrow-derived mononuclear cell transplantation in duchenne muscular dystrophy. Indian Journal of Clinical Practice. 2012;23:169–172.
   Google Scholar
• Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Bone marrow stem cells regenerate infracted myocardium. Pediatr Transplant. 2003;7:86–88.
   PubMed Web of Science ®Google Scholar
• Alok S, Nandini G. Stem cell therapy in neurological disorders In: Sharma A, Gokulchnadran N, editors. Mechanism of Action. Mumbai: Surekha Press; 2010: 61–69.
   Google Scholar
• Skuk D, Roy B, Goulet M, et al Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther. 2004;9:475–482.15038390
   PubMed Web of Science ®Google Scholar
• Blitzblau R, Storer E, Jacob M. Dystrophin and utrophin isoforms are expressed in glia, but not neurons, of the avian parasympathetic ciliary ganglion. Brain Res. 2008;1218:21–34.18533135
   PubMed Web of Science ®Google Scholar
• Luo L, Zhou HY. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011;42(1):101–105. Chinese.21355312
   PubMedGoogle Scholar
• Ragab AH. Motor end plate changes in mouse muscular dystrophy. Lancet. 1971;2:815–816.
   Web of Science ®Google Scholar
• Wahl P, Brixius K, Bloch W. Exercise-induced stem cell activation and its implication for cardiovascular and skeletal muscle regeneration. Minim Invasive Ther Allied Technol. 2008;17:91–99.18465444
   PubMed Web of Science ®Google Scholar